DZP has advised the German pharmaceutical company Wöerwag Pharma GmbH & Co. KG on the acquisition of Sensilab sp. z o.o. SKA, a Polish entity providing research and development services and a contract manufacturer of medicinal products, medical devices and dietary supplements.

By acquiring Sensilab, the German investor gained a new production facility and reliable suppliers, which will enable it to further implement its growth strategy.

Our advice covered all stages of the transaction, from devising the transaction structure, through conducting a comprehensive due diligence (including regulatory aspects), drawing up transaction documentation, and negotiations, to closing the transaction and supporting the client in implementing further measures to incorporate Sensilab into the buyer's group.

The client was advised by DZP lawyers Marek Świątkowki, Partner, Damian Szczygielski, Senior Associate, Michał Klimowicz, Associate, and Joanna Fasula, Associate from the Corporate and M&A Practice, and also Tomasz Kaczyński, Partner, and Aleksandra Bieniek, Associate in the Life Sciences Practice.